Rachel M.A. Linger

Statistics

Publications

Citations

592

H-Index

Active since

2008

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

University of North Carolina at Chapel Hill

UNC Lineberger Comprehensive Cancer Center

Rachel M.A. Linger is an author at University of Colorado Anschutz Medical Campus specializing in mer receptor tyrosine kinase signaling, molecular oncology, and oncology.

ORCID

Publications per year

2008–2014

Publications

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer

Rachel M.A. Linger, Richard A. Cohen, Christopher T. Cummings et al. · Oncogene · 2012 · 217 citations

Life Sciences, Cancer Biology, Oncology +16

Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices

Susan Goebel-Goody, Kurtis D. Davies, Rachel M.A. Linger et al. · Neuroscience · 2008 · 189 citations

Life Sciences, Neurobiology, Neuroscience +14

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Rachel M.A. Linger, Alisa B. Lee‐Sherick, Deborah DeRyckere et al. · Blood · 2013 · 64 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer

Christopher T. Cummings, Rachel M.A. Linger, Rebecca A. Cohen et al. · Oncotarget · 2014 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus

Justine Migdall-Wilson, C Ryan Bates, Jennifer Schlegel et al. · PLoS ONE · 2012 · 37 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–5 of 6